Prevalence of anterior nares colonization of Palestinian diabetic patients with Staphylococcus aureus or methicillin-resistant Staphylococcus aureus

Muna M. Abbas1*, Motasim Almasri2, Alaeddin Abu-Zant2, Shadi Sharef3, Sara Mahajne3, Khalil Kananbi3

1Zarqa University College, Al-Balqa Applied University, Zarqa, Jordan;

2Division of Microbiology, Immunology and Pathology, Department of Biomedical Sciences, College of Medicine and Health Sciences, An-Najah National University, Nablus-Palestine;

3Department of Medicine, College of Medicine and Health Sciences, An-Najah National University, Nablus-Palestine

*Corresponding Author: Muna M. Abbas, Zarqa University College, Al-Balqa Applied University, Zarqa, Jordan. Email: [email protected]


Staphylococcus aureus (S. aureus) is an opportunistic pathogen that colonizes the anterior nares of about one-third of the human population. Anterior nares colonization with S. aureus or methicillin-resistant S. aureus (MRSA) allows these pathogens to colonize the skin and other anatomical locations. Accordingly, these pathogens may cause different types of endogenous infections. To investigate the prevalence of nasal carriage of S. aureus or MRSA among Palestinian diabetic patients, nasal swabs were taken from 151 diabetic patients, about to undergo invasive surgeries. Thirty-five patients (35.1% of the total patients) were found to be colonized with S. aureus, of which 14 (9.7% of the total patients) were found to be colonized with MRSA. These proportions were higher than those described for the general population (30% and 1.3%, respectively) or even for Palestinian patients in general (25.9% and 2%, respectively). In addition, the proportion of nasal carriage of S. aureus or MRSA among Palestinian diabetic patients was found to be higher than that described for diabetic patients in other countries. Meanwhile, 30 of the 53 isolates (57% of the total isolates) were also found to be multidrug-resistant. Accordingly, the proportion of anterior nares colonization with S. aureus or MRSA in Palestinian diabetic patients was remarkably high.

Key words: Palestine, diabetes, S. aureus, MRSA, antibiotic resistance, anterior nares colonization

Received: 5 September 2023; Accepted: 21 September 2023; Published: 4 October 2023

DOI: 10.15586/qas.v15i4.1380

© 2023 Codon Publications
This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0). License (


Staphylococcus aureus (S. aureus) is a member of the human microbiota that mainly colonizes the anterior nares of about 30% of the human population (Aswani and Shukla, 2011; Brown et al., 2014, Yang et al., 2022). From the anterior nares, it spreads to various anatomical locations, such as the skin, throat, and vagina (Jauneikaite et al., 2020). As an opportunistic pathogen, S. aureus causes community or nosocomial-acquired endogenous infections that range from mild to clinically complicated infections associated with high morbidity and mortality rates (Alvarez et al., 2010; Hunt et al., 1988; Vandenesch et al., 2003; Wertheim et al., 2005).

This pathogen expresses several surface-adhesion molecules (adhesions) that promote its attachment to several types of host molecules (receptors), such as laminin and fibronectin, fibrin/fibrinogen, and collagen (Sakr et al., 2018). By its anatomical proximity and adhesion molecules, it rapidly colonizes skin wounds by binding to the exposed receptor molecules found on damaged tissues at the wound site (Birkenhauer et al., 2014; Harris et al., 2002). This is the reason for this pathogen to have the highest proportion of wound-causing infections, compared to other bacterial pathogens (Birkenhauer et al., 2014).

Pathogenic bacteria cause diseases in humans and animals (Hu et al., 2022; Qin et al., 2022; Tian et al., 2022). S. aureus causes invasive skin infections ranging from mild ones, such as folliculitis and boils, to severe infections, such as carbuncles (Singer and Talan, 2014). An untreated abscess may enable S. aureus and/or its toxic-shock syndrome toxin (TSST) to reach the bloodstream and cause toxic shock, a potentially fatal clinical condition associated with high proportions of mortality and morbidity (Fowler et al., 2003; Lowy, 1998). Once the pathogen reaches the bloodstream, it may get seeded into various tissues and organs, causing serious pyogenic inflammations, such as endocarditis, osteomyelitis, and meningitis (Carek et al., 2001; Fernandez Guerrero et al., 2009; Schlesinger et al., 1987).

In addition, this pathogen is considered as one of the leading bacterial pathogens in terms of its ability to develop resistance to many antibiotics (Mlynarczyk-Bonikowska et al., 2022; Pantosti et al., 2007; Zhang et al., 2023). These mechanisms may include the production of antibiotic-inactivating enzymes via genetic mutations that either alter the target site of an antibiotic or reduce its ability to reach the bacterial cytoplasm and efflux pumps (Mlynarczyk-Bonikowska et al., 2022; Pantosti et al., 2007).

The emergence of certain strains that are highly resistant to antibiotics, such as methicillin-resistant S. aureus (MRSA) (Lakhundi and Zhang 2018), and vancomycin- resistant S. aureus (VRSA) (McGuinness et al., 2017), has made the treatment of their infections very complicated and thus giving a chance to infections to become severe and life-threatening (Tarai et al., 2013). Interestingly, the global nasal colonization proportion with MRSA was estimated at about 1.3% (Salgado et al., 2003). Initially, MRSA was mainly associated with nosocomial infections. However, since the 1990s, a significant increase in community-acquired MRSA infections has been reported globally (Berman et al., 1993; Gorak et al., 1999; Herold et al., 1998; Pate et al., 1995).

A study conducted by Gould and Cruickshank (1957) demonstrated that about 86% of patients with S. aureus skin infections were colonized with the same infecting strain in their anterior nares. Another study conducted in 1990 found a significant link between S. aureus nasal colonization and increase in the risk of developing endogenous infections with the same colonizing strain at the exit site of the catheter used in ambulatory peritoneal dialysis (Luzar et al., 1990).

Balanced nutrition has an important role in maintaining adequate immune system that protects us from many microbial infections (Munteanu and Schwartz, 2022). Malnutrition or imbalanced nutrition has a passive effect on the functionality of our immune defenses, and thus rendering us more susceptible to microbial infections as well as development of certain diseases, such as cancer and diabetes (Cui et al., 2020; Foolchand et al., 2022; Gao et al., 2022; Lopez Plaza and Bermejo Lopez, 2017; Saklayen, 2018; Sami et al., 2017).

Hyperglycemia in diabetes has a profound passive effect on immune response to microbial invasion (Berbudi et al., 2020). It has been shown that hyperglycemia interferes with the expression of inflammatory genes of immune cells and thus weakens their inflammatory response to microbial infections (Akbari and Hassan-Zadeh, 2018).

Currently, diabetes is considered as the most common metabolic disorder worldwide, predominantly in low- and middle-income countries (Teufel et al., 2021). Interestingly, a study conducted in 2014 indicated that the global number of diabetic patients is predicted to rise from 382 million in 2013 to 592 million in 2035 (Guariguata et al., 2014). The increase in the prevalence rate of diabetes, mainly in low- and middle-income countries, demands upgrading of intervening procedures that target diabetic patients and may mitigate proportion of both infections and colonization by these pathogens (Stacey et al., 2019).

Many studies have shown that nasal colonization with S. aureus or MRSA is higher in diabetic patients, compared to healthy individuals. In 2017, a study conducted in China found that about 8.7% enrolled diabetic patients were colonized with S. aureus and and 4.1% were colonized by MRSA (Lin et al., 2017). Another study conducted in Turkey in 2006 found that about 35.3% type I and 13.8% type II diabetes enrolled patients were colonized with S. aureus (Tamer et al., 2006). Furthermore, it was found that 2.6% diabetics in Japan and 2.1% diabetics across nine European countries were colonized with MRSA (Stacey et al., 2019). It was shown that S. aureus or MRSA nasal carriage increases the risk of developing diabetic foot infection among diabetic patients (Dawaiwala et al., 2021; Lavery et al., 2014; Lin et al., 2020). Interestingly, nasal decolonization of these pathogens decreases the risk of developing endogenous infections with these pathogens (Lin et al., 2020; Ontario, 2022; Patel et al., 2022).

No previous study has investigated the proportion of nasal colonization with S. aureus or MRSA among diabetic patients in Palestine. The main aim of this study was to investigate this issue in diabetic patients from the northern part of West-Bank, Palestine, who were about to undergo invasive surgery, and to investigate the anti-biotic resistance profiles of colonizing strains.

Materials and Methods

Ethical considerations

Ethical standards and the Declaration of Helsinki were followed while conducting the present study. Institutional Review Board (IRB) committee of the An-Najah National University (ANNU) approved the study (16-10-21). All participants read and declared their consent following relevant guidelines. Written informed consent was obtained from the participants before data collection. Patients included in the study had the right to terminate their involvement at any time during the study, although none of the patients included in the study was forced to do so. In addition, identity of the patients was confidential, and the collected information of each patient was allocated a code number instead of any personal identifying details.

Sampling technique

Nutrient agar, nutrient broth, mannitol sal agar, Mueller Hinton agar, and antibiotic disks were obtained from Oxoid (Basingstoke, Hampshire, UK). Coagulase test was conducted using the Staphylase test kit (Oxoid) according to the manufacturer’s instructions.

Nasal swabs from the anterior nares of 151 diabetic patients who were to undergo invasive surgery at Rafidya Surgical Hospital in Nablus City, in the northern part of West Bank, Palestine, were obtained between November 2021 and July 2022.

Each swab was inoculated into a tube containing 4-mL nutrient broth supplemented with 7.5% sodium chloride (NaCl). The inoculated tubes were then incubated in a shaker incubator at 37ºC under aerobic conditions for 24 h. By the end of the incubation period, each tube was used to inoculate mannitol salt agar plate using the four-quadrant streaking method to obtain separate colonies. After that, the inoculated plates were incubated at 37ºC under aerobic conditions for 24 h. Then, a single yellowish colony (mannitol-fermenting colony) was picked up using a sterile needle and sub-cultured on a nutrient agar plate. The inoculated nutrient agar plates were incubated at 37ºC under aerobic conditions for 24 h. After that, the bacteria grown on each plate were harvested using a sterile cotton swab and suspended in 1-mL nutrient with 40% glycerol using a 2-mL storage cryo-tube. The cryo-tubes were vigorously vortexed and stored at -80ºC for the future use (Howard, 1956).

Bacterial Diagnosis of S. aureus isolates

The content of each of the frozen cryo-tubes was allowed to thaw at room temperature. Then, each of these tubes was used to inoculate nutrient agar plate. After that, the inoculated plates were incubated at 37ºC under aerobic conditions for 24 h.

The grown bacteria were identified as S. aureus based on standard microbiological tests (Patricia, 2017). S. aureus American Type Culture Collection (ATCC) 25923 and a previously confirmed MRSA clinical isolate were used as controls (Adwan, 2014).

Antibiotics susceptibility testing

All of the obtained S. aureus isolates were tested for antibiotic susceptibility to bacitracin (10 µg), cefoxitin (30 μg), clindamycin (2 µg), erythromycin (15 μg), sulfamethoxazole/ trimethoprim (1.25/23.73 μg), linezolid (30 μg), teico-planin (30 µg), vancomycin (30 µg), tetracycline (30 μg), levofloxacin (5 μg), rifampicin (5 µg), azithromycin (15 μg), gentamicin (10 μg), oxacillin (1 μg), and chloramphenicol (30 µg) using the disk-diffusion method based on the guidelines of the Clinical Laboratory Standards Institute (CLSI, 2020).

Briefly, a suspension of each of the obtained isolate was prepared in normal saline at a concentration of 0.5 McFarland (1.5 × 108 CFU/mL). After that, each of the bacterial suspension was used to inoculate three Mueller Hinton agar plates by using a sterile cotton swap. Then by using a disk dispenser, antibiotic disks were placed on the surfaces of inoculated agar plates. After that, the plates were incubated at 35ºC for 18 h under aerobic condition. By the end of the incubation period, inhibitions zones around antibiotic disks were measured and used to determine whether the tested stain was susceptible, intermediate- resistant, or resistant to each of the tested antibiotics.

Each of the obtained S. aureus isolates was sub-cultured on a nutrient agar plate and incubated at 37ºC for 24 h under aerobic conditions. After that, a bacterial suspension of 0.5 McFarland was prepared from each of the grown isolates. Each bacterial suspension was used to inoculate two Mueller Hinton agar plates using a sterile cotton swab. The discs of the above-mentioned anti-biotics were distributed evenly on the surfaces of the inoculated plates of each isolate. Then the plates were incubated at 35ºC for 18 h under aerobic conditions. After that, the inhibition zone around each of the used antibiotic discs was measured in millimeter, and each of the obtained isolates was determined as susceptible, intermediate-resistant, or resistant to each antibiotic based on the CLSI (2020) guidelines.

Identification of MRSA in the obtained isolates

MRSA was identified in the obtained S. aureus isolates based on cefoxitin resistance as recommended by CLSI (2020) guidelines.

Results and Discussion

Proportion of S. aureus and MRSA anterior nares colonization in diabetic patients

Diabetes is a global health problem with several clinical complications significantly affecting global mortality (van der Berg et al., 2016; Zheng et al., 2018; Zimmet et al., 2014). In the Middle East, about 46-million patients had type 2 diabetes between 2000 and 2018 (Kalan Farmanfarma et al., 2020).

In Palestine, the proportion of diabetes mellitus in 2015 was estimated to be about 18.4%. However, this proportion was expected to become 21.5% by 2030 (Abu-Rmeilehi et al., 2013). More importantly, diabetes in Palestine was expected to grow as one of the leading causes of morbidity and mortality, compared to other Middle East countries, indicating that diabetes and its potential complications, including the growth of microbial infections, is becoming a major health problem (Husseini et al., 2009, Rahim et al. 2014). A possible explanation for increase in the prevalence of diabetes among Palestinians could be attributed to increase in the proportion of consumption of food and drinks high in fat and sugar as well as decrease in the pattern of physical activities (Al Sabbah et al., 2007; Mikki et al., 2010).

As mentioned earlier, the main goal of this quantitative descriptive cross-sectional study was to determine the prevalence of nasal colonization with S. aureus or MRSA among diabetic patients who were to undergo invasive surgeries. To achieve this objective, initially, nasal swabs from 151 patients (mean age 54.85 ± 6.30 years), including 86 (57%) males and 65 (43%) females, with type II diabetes were obtained (Table 1). Of the 151 patients, 53 (35.1%) were found to be colonized with S. aureus in the anterior nares.

Table 1. Number, gender, and mean age of the patients.

Total patients Number (%) Mean age (±SD)
151 (100%) 54.8 (6.5)
Males 86 (57%) 52.3 (6.6)
Females 65 (43%) 55.6 (5.4)

Methicillin-resistant S. aureus was identified among the obtained isolates based on susceptibility to cefoxitin (30 μg) as recommended by CLSI (2020). Identification of MRSA based on cefoxitin resistance is shown to have 100% sensitivity and 100% specificity, compared to defection in mecA gene by Polymerase chain reaction (PCR) (Koupahi et al., 2016). Among the obtained 53 S. aureus isolates, 14 (9.7% of total patients) were found as MRSA isolates.

Although some studies reported no significant difference in the proportion of S. aureus nasal colonization between diabetic patients and healthy individuals (Essigmann et al., 2022), many studies reported that diabetes mellitus is one risk factor that increases the possibility of anterior nares colonization with S. aureus (Lin et al., 2017; Stacey et al., 2019; Tamer et al., 2006). Increase in the prevalence rate of S. aureus anterior nares colonization could be explained based on the negative impact of diabetes on host immune defenses, particularly innate immunity (Geerlings and Hoepelman, 1999; Lipsky et al., 1987; Sakr et al., 2018). In addition, it is established that increase in glycosylated hemoglobin (HbA1c) level in diabetic patients significantly increases the proportion of S. aureus anterior nares colonization, and oral hypoglycemic agents decrease this proportionality (Lin et al., 2020).

The results of the current study revealed that the proportion of S. aureus and MRSA nasal colonization among diabetic patients at the time of their admission was about 35.1% and 9.7%, respectively. These proportions were higher than the general proportions of nasal colonization with S. aureus and MRSA obtained by a cross-sectional study conducted in Palestine in 2009 (Kaibni et al., 2009). In the cited study, it was found that at the time of hospitalization, about 25.9% and 2% of 834 patients were nasally colonized with S. aureus and MRSA, respectively (Kaibni et al., 2009).

In addition, our results indicated that the proportion of nasal colonization with S. aureus (35.1%) was higher than the proportion (approximately 30%) reported in the general population (Aswani and Shukla 2011; Brown et al., 2014). This result was supported by other studies showing that diabetes increases S. aureus anterior nares colonization (Kluytmans et al., 1997; Tamer et al., 2006).

Furthermore, the higher proportions of S. aureus and MRSA nasal colonization found in the present study among diabetic patients (35.1% and 9.7%, respectively) were higher than those reported for diabetic patients in other countries. A study conducted in China showed that 8.7% and 4.1% of enrolled diabetic patients were colonized with S. aureus and MRSA, respectively (Lin et al., 2017). Another study conducted in Ghana reported that 31.0% and 3.3% of diabetic patients were colonized with S. aureus and MRSA, respectively (Anafo et al., 2021). In addition, a meta-analysis study comprising both diabetic inpatients and outpatients from different countries and regions (East Asia, the Middle East, Germany, Taiwan, and the United States) established that the proportions of anterior nares colonization with S. aureus and MRSA were 13.46% and 8.33%, respectively (Stacey et al., 2019). In this study, we observed a lower proportion of anterior nares colonization among diabetic patients (9.7%) than the one reported by an earlier meta-analysis study (Stacey et al., 2019). However, the proportion obtained in our study was higher than the proportion of MRSA anterior nares colonization among diabetic outpatients (8.33%) reported by the cited study.

The high proportion of MRSA nasal colonization in diabetic patients reported by our study (9.7%) reflected that prescription and utilization of antibiotics were greatly misused in Palestine (Abu Taha et al., 2016; Zyoud et al., 2015).

Antibiotic susceptibility profiles of obtained isolates

The antibiotic susceptibility profiles of 15 antibiotics were examined for each of the obtained isolates using the disc diffusion method (Table 2 and Figure 1). The highest proportion of resistance was observed for bacitracin, azithromycin, and erythromycin, which was 33 (62.3 %), 26 (49%), and 21 (39.6%) of the obtained isolates, respectively. On the other hand, the lowest proportion of resistance was observed for rifampicin and linezolid, being 2 (3.8%) of the obtained isolates for each of them. Meanwhile, none of the obtained isolates resisted teicoplanin and vancomycin (Table 2 and Figure 1).

Table 2. Number (%) of the obtained S. aureus isolates that were resistant (R), intermediate-resistant (IR), or susceptible (S) to each of the used antibiotics.

Antibiotic R IR S
Number (%) Number (%) Number (%)
Bacitracin 33 (62.3) 17 (32.1) 3 (5.7)
Azithromycin 26 (49) 11 (20.8) 16 (30.2)
Erythromycin 21 (39.6) 13 (24.5) 19 (35.9)
Gentamicin 18 (34) 4 (7.5) 31 (58.5)
Levofloxacin 15 (28.3) 4 (7.6) 43 (64.1)
Cefoxitin 14 (26.4) 0 (0) 39 (73.6)
Sulfa/ trimethoprim 11 (20.8) 0 (0) 42 (79.2)
Oxacillin 10 (18.5) 3 (5.5) 40 (75.5)
Tetracycline 6 (11.3) 1 (1.9) 46 (86.8)
Clindamycin 5 (9.4) 4 (7.6) 44 (83)
Chloramphenicol 5 (9.4) 1 (1.9) 47 (88.7)
Rifampicin 2 (3.8) 0 (0) 51 (96.2)
Linezolid 2 (3.8) 0 (0) 51 (96.2)
Teicoplanin 0 (0) 0 (0) 53 (100)
Vancomycin 0 (0) 0 (0) 53 (100)

Figure 1. The prevalence proportion of antibiotics susceptibility profiles of the obtained isolates.

Bacitracin is a polypeptide antibiotic used to prepare ointments commonly prescribed globally to treat minor skin injuries, such as cuts, scrapes, and burns (Nguyen et al., 2022). This could explain the high prevalence of resistance among the S. aureus isolates obtained in our study (62.3%) and other studies (Nguyen et al., 2022).

Many studies have reported the isolation of teicoplanin- and/or vancomycin-resistant S. aureus from clinical samples or anterior nares swabs (Banerjee and Anupurba, 2012; El Sayed et al., 2018; Sujatha and Praharaj, 2012; Szymanek-Majchrzak et al., 2018). The fact that none of the isolates obtained in the present study showed resistance to any of these two antibiotics (see Table 2 and Figure 1) could be due to the rare use of these two antibiotics in Palestine.

Table 3 shows the resistance proportion of the obtained S. aureus isolate s to some of the antibiotics utilized in this study, compared to the proportion of resistance of the same antibiotics by S. aureus isolates obtained by the studies conducted in other countries.

Table 3. Proportion of resistance of the obtained S. aureus isolates to some of the utilized antibiotics, compared to the proportion of resistance of the same antibiotics by similar isolates in other countries.

Antibiotic Proportion of resistance (%) of S. aureus isolates to certain antibiotics in other countries
Palestine Italy Europe
Erythromycin 39.62 34.7 16.5
Gentamicin 33.96 8.4 2.2
Oxacillin 18.87 3.2
Fluoroquinolones 28.3 8.4 5.2
Cefoxitin 26.4 3.3
Sulfa/trimethoprim 20.75 1.1 1.9
Linezolid 3.77 22.1
Tetracycline 11.32 2.8 3.0

Table 3 clearly shows that, except for the proportion of resistance to linezolid, proportion of resistance to other antibiotics was higher than those of the same antibiotics exhibited by S. aureus isolates obtained in Italy (Mascaro et al., 2019). Interestingly, the proportion of resistance of isolates obtained in our study to erythromycin (39.62%), gentamicin (33.96%), fluoroquinolones (28.3%), sulfamethoxazole/trimethoprim (20.75%), and tetracycline (11.32%) was higher than the proportion of resistance to the same antibiotics for isolates obtained in Europe (16.5%, 2.2%, 5.2%, 1.9%, and 3.0%, respectively; Table 2 and Figure 1).

The misuse of prescription and utilization of antibiotics is not only a driving force for the emergence and spread of MRSA in community but also a driving force for the development and spread of multidrug resistant bacteria pathogens (Medina and Pieper, 2016; Ventola, 2015). A multidrug bacterial pathogen is defined as the pathogen that is resistant to at least one antibiotic of three or four categories of antibiotics (Magiorakos et al., 2012).

Although our results showed that 3 (5.7%) of the obtained isolates were susceptible to all of the used antibiotics, 20 (37.8%) of the obtained isolates were resistant to 1–2 of the used antibiotics, 18 (33.9%) of the obtained isolates were resistant to 3–4 of the used antibiotics, 5 (9.5%) of the obtained isolates were resistant to 5–6 of the used antibiotics, 6 (11.3%) of the obtained isolates were resistant to 7–8 of the used antibiotics, and only 1 (1.9%) of the obtained isolates was resistant to 9 of the used antibiotics (Table 4).

Table 4. Number (%) of S. aureus isolates susceptibly to or resistant to one or more of the used antibiotics.

Number (%) of isolates Number of antibiotics to which the isolates were resistant
3 (5.7%) No antibiotic
10 (18.9%) 1 antibiotic
10 (18.9%) 2 antibiotics
12 (22.6%) 3 antibiotics
6 (11.3%) 4 antibiotics
3 (5.7%) 5 antibiotics
2 (3.8%) 6 antibiotics
4 (7.5%) 7 antibiotics
2 (3.8%) 8 antibiotics
1 (1.9%) 9 antibiotics

Our results indicated that 30 (57%) of our isolates were multidrug-resistant isolates (Table 4), a percentage that could be considered seriously alarming, because such multidrug-resistant isolates could cause endogenous infections that are clinically challenging in terms of their treatment.

The data presented in Tables 2 and 3 and Figure 1 clearly show that the prevalence of antibiotic resistance of S. aureus isolates in Palestine has reached alarming proportions, which reflect, as mentioned earlier, the misuse of prescription and utilization of antibiotics in Palestine (Abu Taha et al., 2016; Zyoud et al., 2015).

S. aureus can cause various types of infections (Lowy, 1998). Interestingly, most of these infections are endogenous, caused by the same strains that colonize the anterior nares of patients (Wertheim et al., 2005). The fact that about 57% of the obtained S. aureus isolates in the current study were multidrug-resistant isolates (see Table 4), endogenous infections caused by these could be clinically complicated and life-threatening.


Our results indicated that about 35.1% of the enrolled patients in this study were colonized with S . aureus, of which 23% were colonized with MRSA, and more than half (57%) of the isolates were multidrug-resistant isolates. Importantly, our findings elucidated the importance of screening of Palestinian diabetic patients for S. aureus or MRSA nasal colonization who were to undergo invasive surgery and implementing a decolonization plan to minimize the risk of developing endogenous surgical wound infections or other infections.

A relatively small number of enrolled patients were one of the limitations of this study. In addition, our experimental procedures did not include molecular methods that could be used to confirm the genetic basis of antibiotic resistance.

Availability of data and materials

The datasets used and/or analyzed in the study are available from the corresponding author upon reasonable request.

Author contributions

The study was designed by Muna M. Abbas, Motasim Almasri, and Alaeddin Abu-Zant. Data were analyzed by Shadi Sharef and Sara Mahajne. Manuscript was prepared by Muna M. Abbas, Alaeddin Abu-Zant, Motasim Almasri, and Khalil Kananbi.


The authors thank the medical and administration staff of Rafidya Surgical Hospital, as well as the technicians of the microbiology laboratory of the College of Medicine and Health Sciences, An-Najah National University, for facilitating this study. In addition, the authors thank the administration of the College of Medicine and Health Sciences, An-Najah National University, for providing financial requisites for the study.


Abu-Rmeileh, N.M., Husseini, A., Capewell, S. and O’Flaherty, M. 2013. Preventing type 2 diabetes among Palestinians: comparing five future policy scenarios. BMJ Open 3(12): e003558. 10.1136/bmjopen-2013-003558

Abu Taha, A., Abu-Zaydeh, A.H.R.A., Ardah, S.W., Al-Jabi, W.M., Sweileh, R. and Awang, S.H. 2016. Public knowledge and attitudes regarding the use of antibiotics and resistance: findings from a cross-sectional study among Palestinian adults. Zoonoses Public Health 63(6): 449–457. 10.1111/zph.12249

Adwan, K. 2014. Fast DNA isolation and PCR protocols for detection of methicillin-resistant staphylococci. Folia Microbiology (Praha) 59(1): 5–8. 10.1007/s12223-013-0259-1

Akbari, M. and Hassan-Zadeh, V. 2018. Hyperglycemia affects the expression of inflammatory genes in peripheral blood mononuclear cells of patients with type 2 diabetes. Immunological Investigations 47(7): 654–665. 10.1080/08820139.2018.1480031

Al Sabbah, H., Vereecken, C., Kolsteren, P., Abdeen, Z. and Maes, L. 2007. Food habits and physical activity patterns among Palestinian adolescents: findings from the national study of Palestinian schoolchildren (HBSC-WBG2004). Public Health Nutrition 10(7): 739–746. 10.1017/S1368980007665501

Alvarez, C.A., Yomayusa, N., Leal, A.L., Moreno, J., Mendez-Alvarez, S., Ibañez, M. and Vanegas, N. 2010. Nosocomial infections caused by community-associated methicillin-resistant Staphylococcus aureus in Colombia. American Journal of Infection Control 38(4): 315–318. 10.1016/j.ajic.2009.05.013

Anafo, R.B., Atiase, Y., Kotey, F.C.N., Dayie, N.T.K.D., Tetteh-Quarcoo, P.B., Duodu, S. et al. 2021. Methicillin-resistant Staphylococcus aureus (MRSA) nasal carriage among patients with diabetes at the Korle Bu Teaching Hospital. PLoS One 16(9): e0257004. 10.1371/journal.pone.0257004

Aswani, V.H. and Shukla, S.K. 2011. Prevalence of Staphylococcus aureus and lack of its lytic bacteriophages in the anterior nares of patients and healthcare workers at a rural clinic. Clinical Medical Research 9(2): 75–81. 10.3121/cmr.2010.954

Banerjee, T. and Anupurba, S. 2012. Colonization with vancomycin-intermediate Staphylococcus aureus strains containing the vanA resistance gene in a tertiary-care center in north India. Journal of Clinical Microbiology 50(5): 1730–1732. 10.1128/JCM.06208-11

Berbudi, A., Rahmadika, N., Tjahjadi, A.I. and Ruslami, R. 2020. Type 2 diabetes and its impact on the immune system. Current Diabetes Review 16(5): 442–449. 10.2174/1573399815666191024085838

Berman, D.S. and Eisner, W. 1993. Community-acquired methicillin-resistant Staphylococcus aureus infection. New England Journal of Medicine 329(25): 1896. 10.1056/NEJM199312163292517

Birkenhauer, E., Neethirajan, S. and Birkenhauer, E. 2014. Collagen and hyaluronan at wound sites influence early polymicrobial biofilm adhesive events. BMC Microbiology 14: 191. 10.1186/1471-2180-14-191

Brown, A.F., Leech, J.M. and Brown, A.F. 2014. Staphylococcus aureus colonization: modulation of host immune response and impact on human vaccine design. Frontiers in Immunology 4: 507. 10.3389/fimmu.2013.00507

Carek, P.J., Dickerson, L.M. and Sack, J.L. 2001. Diagnosis and management of osteomyelitis. American Family Physician 63(12): 2413–2420.

Clinical Laboratory Standards Institute (CLSI). 2020. Performance standards for antimicrobial susceptibility testing. Available at: (Accessed February, 2021).

Cui, G., Zhao, K., You, K., Gao, Z., Kakuchi, T., Feng, B. and Duan, Q. 2020. Synthesis and characterization of phenylboronic acid-containing polymer for glucose-triggered drug delivery+. Science and Technology of Advanced Materials 21(1): 1–10. 10.1080/14686996.2019.1700394

Dawaiwala, I., Awaghade, S., Kolhatkar, P., Pawar, S. and Barsode, S. 2021. Microbiological pattern, antimicrobial resistance and prevalence of MDR/XDR organisms in patients with diabetic foot infection in an Indian tertiary care hospital. International Journal of Lower Extremity Wounds 12(3): 47–53. 10.1177/15347346211038090

El Sayed, N., Ashour, M. and Amine, A.E.K. 2018. Vancomycin resistance among Staphylococcus aureus isolates in a rural setting, Egypt. Germs 8(3): 134–139. 10.18683/germs.2018.1140

Essigmann, H.T., Hanis, C.L., DeSantis, S.M., Perkison, W.B., Aguilar, D.A., Jun, G.D. and Robinson, A. and Brown, E.L. 2022. Worsening glycemia increases the odds of intermittent but not persistent Staphylococcus aureus nasal carriage in two cohorts of Mexican-American adults. Microbiology Spectrum 10(3): e0000922. 10.1128/spectrum.00009-22

Fernández Guerrero, M.L., González López, J.J., Goyenechea, A., Fraile, J. and de Górgolas, M. 2009. Endocarditis caused by Staphylococcus aureus: a reappraisal of the epidemiologic, clinical, and pathologic manifestations with analysis of factors determining outcome. Medicine (Baltimore) 88(1): 1–22. 10.1097/MD.0b013e318194da65

Foolchand, A. and Ghazi, T. 2022. Malnutrition and dietary habits alter the immune system which may consequently influence SARS-CoV-2 virulence: a review. International Journal of Molecular Sciences 23(5): 46–53. 10.3390/ijms23052654

Fowler, V.G., Olsen, M.K. and Corey, G.R. 2003. Clinical identifiers of complicated Staphylococcus aureus bacteremia. Archives of Internal Medicine 163(17): 2066–2072. 10.1001/archinte.163.17.2066

Gao, G., Pan, X., Shao, J., Jiang, X., Su, Z., Jin, K. and Ye, J. 2022. Automatic interpretation and clinical evaluation for fundus fluorescein angiography images of diabetic retinopathy patients by deep learning. British Journal of Ophthalmology 15(2): 36–46. 10.1136/bjo-2022-321472

Geerlings, S.E. and Hoepelman, A.I. 1999. Immune dysfunction in patients with diabetes mellitus (DM). FEMS Immunology and Medical Microbiology 26(3–4): 259–265. 10.1111/j.1574-695X.1999.tb01397.x

Gorak, E.J., Yamada, S.M. and Brown, J.D. 1999. Community-acquired methicillin-resistant Staphylococcus aureus in hospitalized adults and children without known risk factors. Clinical Infectious Diseases 29(4): 797–800. 10.1086/520437

Gould, J.C. and Cruikshank, J.D. 1957. Staphylococcal infection in general practice. Lancet 273(7006): 1157–1161. 10.1016/S0140-6736(57)92063-9

Guariguata, L., Whiting, D.R., Hambleton, I., Beagley, J., Linnenkamp, U. and Shaw, J.E. 2014. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Research and Clinical Practice 103(2): 137–149. 10.1016/j.diabres.2013.11.002

Harris, L.G., Foster, S.J. and Richards, R.G. 2002. An introduction to Staphylococcus aureus, and techniques for identifying and quantifying S. aureus adhesins in relation to adhesion to biomaterials: review. European Cells & Materials 4: 39–60. 10.22203/ecm.v004a04

Herold, B.C., Immergluck, L.C. and Maranan, M.C. 1998. Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. Journal of American Medical Association (JAMA) 279(8): 593–598. 10.1001/jama.279.8.593

Howard, D.H. 1956. The preservation of bacteria by freezing in glycerol broth. Journal of Bacteriology 71(5): 625. 10.1128/jb.71.5.625-625.1956

Hu, B., Das, P., Lv, D., Shi, M., Aa, J., Wang, K. et al. 2022. Effects of healthy’fecal microbiota transplantation against the deterioration of depression in fawn-hooded rats. Msystems 7(3): e00218–e00222. 10.1128/msystems.00218-22

Hunt, J.L., Purdue, G.F. and Tuggle, D.W. 1988. Morbidity and mortality of an endemic pathogen: methicillin-resistant Staphylococcus aureus. American Journal of Surgery 156(6): 524–528. 10.1016/S0002-9610(88)80545-2

Husseini, A., Abu-Rmeileh, N.M.E., Mikki, N. and Ramahi, TM. 2009. Cardiovascular diseases, diabetes mellitus, and cancer in the occupied Palestinian territory. Lancet 373(9668): 1041–1049. 10.1016/S0140-6736(09)60109-4

Jauneikaite, E., Ferguson, T., Mosavie, M., Fallowfield, J.L., Davey, T., Thorpe, N. et al. 2020. Staphylococcus aureus colonization and acquisition of skin and soft tissue infection among Royal Marines recruits: a prospective cohort study. Clinical Micro-biology and Infection 26(3): 381 e381–381 e386. 10.1016/j.cmi.2019.07.014

Kaibni, M.H., Farraj, M.A., Adwan, K. and Essawi, T.A. 2009. Community-acquired meticillin-resistant Staphylococcus aureus in Palestine. Journal of Medical Microbiology 58(Pt 5): 644–647. 10.1099/jmm.0.007617-0

Kalan Farmanfarma, K.H., Ansari-Moghaddam, A., Zareban, I. and Adineh, H.A. 2020. Prevalence of type 2 diabetes in Middle-East: systematic review & meta-analysis. Primary Care Diabetes 14(4): 297–304. 10.1016/j.pcd.2020.01.003

Kluytmans, J. van Belkum, A. and Verbrugh, H. 1997. Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clinical Microbiology Reviews 10(3): 505–520. 10.1128/CMR.10.3.505

Koupahi, H., Jahromy, S.H. and Rahbar, M. 2016. Evaluation of different phenotypic and genotypic methods for detection of methicillin-resistant Staphylococcus aureus (MRSA). Iranian Journal of Pathology 11(4): 370–376.

Lakhundi, S. and Zhang, K. 2018. Methicillin-resistant Staphylo-coccus aureus: molecular characterization, evolution, and epidemiology. Clinical Microbiology Reviews 31(4): 25–36. 10.1128/CMR.00020-18

Lavery, L.A., La Fontaine, J., Bhavan, K., Kim, P.J., Williams, J.R. and Hunt, N.A. 2014. Risk factors for methicillin-resistant Staphylococcus aureus in diabetic foot infections. Diabetic Foot & Ankle 5(1): 25–36. 10.3402/dfa.v5.23575

Lin, J., Xu, P., Peng, Y., Lin, D., Ou, D., Zhang, T., Bai, C. et al. 2017. Prevalence and characteristics of Staphylococcus aureus and methicillin-resistant Staphylococcus aureus nasal colonization among a community-based diabetes population in Foshan, China. Journal of Diabetes Investigation 8(3): 383–391. 10.1111/jdi.12591

Lin, S-Y., Lin, N-Y., Huang, Y-Y., Hsieh, C-C. and Huang, Y-C. 2020. Methicillin-resistant Staphylococcus aureus nasal carriage and infection among patients with diabetic foot ulcer. Journal of Microbiology, Immunology and Infection 53(2): 292–299. 10.1016/j.jmii.2018.03.005

Lipsky, B.A., Pecoraro, R.E., Chen, M.S. and Koepsell, T.D. 1987. Factors affecting staphylococcal colonization among NIDDM outpatients. Diabetes Care 10(4): 483–486. 10.2337/diacare.10.4.483

Lopez Plaza, B. and Bermejo Lopez, L.M. 2017. Nutrition and immune system disorders. Nutrición Hospitalaria 34(Suppl 4): 68–71. 10.20960/nh.1575

Lowy, F.D. 1998. Staphylococcus aureus infections. New England Journal of Medicine 339(8): 520–532. 10.1056/NEJM199808203390806

Coles, G.A., Faller, B., Slingeneyer, A., Dah, G.A., Briat, C. et al. 1990. Staphylococcus aureus nasal carriage and infection in patients on continuous ambulatory peritoneal dialysis. New England Journal of Medicine 322(8): 505–509. 10.1056/NEJM199002223220804

Magiorakos, A.P., Srinivasan, A., Carey, R.B., Carmeli, Y., Falagas, M.E., Giske, C.G. et al. 2012. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clinical Microbiology and Infection 18(3): 268–281. 10.1111/j.1469-0691.2011.03570.x

Mascaro, V., Squillace, L., Nobile, C.G.A., Papadopoli, R., Bosch, T., Schouls, L.M. et al. 2019. Prevalence of methicillin-resistant Staphylococcus aureus (MRSA) carriage and pattern of anti-biotic resistance among sheep farmers from southern Italy. Infection and Drug Resistance 12: 2561–2571. 10.2147/IDR.S211629

McGuinness, W.A., Malachowa, N. and DeLeo, F.R. 2017. Vancomycin resistance in Staphylococcus aureus. Yale Journal of Biology and Medicine 90(2): 269–281.

Medina, E. and Pieper, D.H. 2016. Tackling threats and future problems of multidrug-resistant bacteria. Current Topics in Microbiology and Immunology 398: 3–33. 10.1007/82_2016_492

Mikki, N., Abdul-Rahim, H.F., Shi, Z. and Holmboe-Ottesen, G. 2010. Dietary habits of Palestinian adolescents and associated sociodemographic characteristics in Ramallah, Nablus and Hebron governorates. Public Health Nutrition 13(9): 1419–1429. 10.1017/S1368980010000662

Mlynarczyk-Bonikowska, B., Kowalewski, C., Krolak-Ulinska, A. and Marusza, W. 2022. Molecular mechanisms of drug resistance in Staphylococcus aureus. International Journal of Molecular Science 23(15): 8088. 10.3390/ijms23158088

Munteanu, C. and Schwartz, B. 2022. The relationship between nutrition and the immune system. Frontiers in Nutrition 9: 1082500. 10.3389/fnut.2022.1082500

Nguyen, R. et al. 2022. Bacitracin topical. StatPearls, Treasure Island, FL.

Ontario, H. 2022. Pre-surgical nasal decolonization of Staphylo-coccus aureus: a health technology assessment. Ontario Health Technology Assessment 22(4): 1–165.

Pantosti, A., Sanchini, A. and Monaco, M. 2007. Mechanisms of antibiotic resistance in Staphylococcus aureus. Future in Microbiology 2(3): 323–334. 10.2217/17460913.2.3.323

Pate, K.R., Nolah, R.L., Bannerman, T.L. and Feldman, S. 1995. Methicillin-resistant Staphylococcus aureus in the community. Lancet 346(8980): 978. 10.1016/S0140-6736(95)91605-9

Patel, N., Gold, J., Brown, N.J., Abraham, M., Beyer, R.S., Yang, C. et al. 2022. Staphylococcus aureus swabbing and decolonization before neuromodulation procedures: a systematic review and meta-analysis. Neuromodulation 26(5): 928–937. 10.1016/j.neurom.2022.07.013

Patricia, M. 2017. Bailey & Scott’s diagnostic microbiology. Elsevier, St Louis, MO.

Qin, X., Zhang, K., Fan, Y., Fang, H., Nie, Y. and Wu, X-L. 2022. The bacterial MtrAB two-component system regulates the cell wall homeostasis responding to environmental alkaline stress. Microbiology Spectrum 10(5): e02311–e02322. 10.1128/spectrum.02311-22

Rahim, H.F.A., Sibai, A., Khader, Y., Hwalla, N., Fadhil, I., Alsiyabi, H., et al. 2014. Non-communicable diseases in the Arab world. Lancet 383(9914): 356–367. 10.1016/S0140-6736(13)62383-1

Saklayen, M.G. 2018. The global epidemic of the metabolic syndrome. Current Hypertension Reports 20(2): 12. 10.1007/s11906-018-0812-z

Sakr, A., Brégeon, F., Mège, J-L., Rolain, J-M., Blin, O. 2018. Staphylococcus aureus nasal colonization: an update on mechanisms, epidemiology, risk factors, and subsequent infections. Frontiers in Microbiology 9: 2419. 10.3389/fmicb.2018.02419

Salgado, C.D., Farr, B.M. and Calfee, D.P. 2003. Community-acquired methicillin-resistant Staphylococcus aureus: a meta-analysis of prevalence and risk factors. Clinical Infectious Diseases 36(2): 131–139. 10.1086/345436

Sami, W., Ansari, T., Butt, N.S. and Ab Hamid, M.R. 2017. Effect of diet on type 2 diabetes mellitus: a review. International Journal of Health Sciences (Qassim) 11(2): 65–71.

Schlesinger, L.S., Stephen, C.R. and Dennis, R.G. 1987. Staphylo-coccus aureus meningitis: a broad-based epidemiologic study. Medicine (Baltimore) 66(2): 148–156. 10.1097/00005792-198703000-00006

Singer, A.J. and Talan, D.A. 2014. Management of skin abscesses in the era of methicillin-resistant Staphylococcus aureus. New England Journal of Medicine 370(11): 1039–1047. 10.1056/NEJMra1212788

Stacey, H.J., Clements, C.S., Welburn, S.C. and Jones, J.D. 2019. The prevalence of methicillin-resistant Staphylococcus aureus among diabetic patients: a meta-analysis. Acta Diabetology 56(8): 907–921. 10.1007/s00592-019-01301-0

Sujatha, S. and Praharaj, I. 2012. Glycopeptide resistance in gram-positive cocci: a review. Interdisciplinary Perspectives on Infectious Diseases 2012: 781679. 10.1155/2012/781679

Szymanek-Majchrzak, K., Mlynarczyk, A. and Mlynarczyk, G. 2018. Characteristics of glycopeptide-resistant Staphylococcus aureus strains isolated from inpatients of three teaching hospitals in Warsaw, Poland. Antimicrobial Resistance & Infection Control 7: 105. 10.1186/s13756-018-0397-y

Tamer, A., Karabay, O. and Ekerbicer, H. 2006. Staphylococcus aureus nasal carriage and associated factors in type 2 diabetic patients. Japan Journal of Infectious Diseases 59(1): 10–14.

Tarai, B., Das, P. and Kumar, D. 2013. Recurrent challenges for clinicians: emergence of methicillin-resistant Staphylococcus aureus, vancomycin resistance, and current treatment options. Journal of Laboratory Physicians 5(2): 71–78. 10.4103/0974-2727.119843

Teufel, F., Seiglie, J.A., Geldsetzer, P., Theilmann, M., Marcus, M.E., Ebert, C., Arboleda, W.A.L. et al. 2021. Body-mass index and diabetes risk in 57 low-income and middle-income countries: a cross-sectional study of nationally representative, individual-level data in 685 616 adults. Lancet 398(10296): 238–248. 10.1016/S0140-6736(21)00844-8

Tian, Z., Zhang, Y., Zheng, Z., Zhang, M., Zhang, T., Jin, J. et al. 2022. Gut microbiome dysbiosis contributes to abdominal aortic aneurysm by promoting neutrophil extracellular trap formation. Cell Host & Microbe 30(10): 1450–1463. e1458. 10.1016/j.chom.2022.09.004

van der Berg, J.D., Stehouwer, C.D.A., Bosma, H., van der Velde, J.H.P.M., Willems, P.J.B., Savelberg, H.H.C.M. et al. 2016. Associations of total amount and patterns of sedentary behaviour with type 2 diabetes and the metabolic syndrome: the Maastricht study. Diabetologia 59(4): 709–718. 10.1007/s00125-015-3861-8

Vandenesch, F., Naimi, T., Enright, M.C., Lina, G., Nimmo, G.R., Heffernan, H. et al. 2003. Community-acquired methicillin-resistant Staphylococcus aureus carrying panton-valentine leukocidin genes: worldwide emergence. Emerging Infectious Diseases 9(8): 978–984. 10.3201/eid0908.030089

Ventola, C.L. 2015. The antibiotic resistance crisis: part 1: causes and threats. Physical Therapy 40(4): 277–283.

Wertheim, H.F., Melles, D.C., Vos, M.C., van Leeuwen, W., van Belkum, A., Verbrugh, H.A. and Nouwen, J.L. 2005. The role of nasal carriage in Staphylococcus aureus infections. Lancet Infectious Diseases 5(12): 751–762. 10.1016/S1473-3099(05)70295-4

Yang, R., Hou, E., Cheng, W., Yan, X., Zhang, T., Li, S. et al. 2022. Membrane-targeting neolignan-antimicrobial peptide mimic conjugates to combat methicillin-resistant Staphylococcus aureus (MRSA) infections. Journal of Medicinal Chemistry 65(24): 16879–16892. 10.1021/acs.jmedchem.2c01674

Zhang, N., Lu, D., Sheng, H., Xia, J., Kan, P., Yao, Z. et al. 2023. Constructed wetlands as hotspots of antibiotic resistance genes and pathogens: evidence from metagenomic analysis in Chinese rural areas. Journal of Hazardous Materials 447: 130778. 10.1016/j.jhazmat.2023.130778

Zheng, Y., Ley, S.H. and Hu, F.B. 2018. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nature Reviews Endocrinology 14(2): 88–98. 10.1038/nrendo.2017.151

Zimmet, P.Z., Magliano, D.J., Herman, W.H. and Shaw, J.E. 2014. Diabetes: a 21st century challenge. Lancet Diabetes and Endocrinology 2(1): 56–64. 10.1016/S2213-8587(13)70112-8

Zyoud, S.H., Taha, A.A., Araj, K.F., Abahri, I.A., Sawalha, A.F., Sweileh, W.M. et al. 2015. Parental knowledge, attitudes and practices regarding antibiotic use for acute upper respiratory tract infections in children: a cross-sectional study in Palestine. BMC Pediatrics 15: 176. 10.1186/s12887-015-0494-5